TLS Advisors LLC
- SEC CIK
- 0001768824
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 7, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 15
- 0 vs. Q4 2023
- Portfolio value
- $40.5M
- +$10.3M (+34.2%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RIORio Tinto PLC | ADR | 103,100 | $6.57M | 16.2% | +78,800+324.3% | Added | History |
| BHPBHP Group Ltd | ADR | 111,960 | $6.46M | 16.0% | +84,300+304.8% | Added | History |
| EQTEQT Corp | Stock | 150,800 | $5.59M | 13.8% | −459−0.3% | Reduced | History |
| METAMeta Platforms, Inc. | Stock | 10,589 | $5.14M | 12.7% | 00.0% | Unchanged | History |
| VALEVale S.A. | SPONSORED ADS | 368,000 | $4.49M | 11.1% | +339,200+1,177.8% | Added | History |
| OVIDOvid Therapeutics Inc. | COM | 1,319,679 | $4.03M | 9.9% | 00.0% | Unchanged | History |
| XOMAXOMA Royalty Corp | COM NEW | 120,365 | $2.90M | 7.2% | −100−0.1% | Reduced | History |
| RRCRange Resources Corp | COM | 47,923 | $1.65M | 4.1% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 32,956 | $1.42M | 3.5% | 00.0% | Unchanged | History |
| OABIOmniAb, Inc. | COM | 250,185 | $1.36M | 3.4% | 00.0% | Unchanged | History |
| HOVHovnanian Enterprises Inc | CL A NEW | 3,872 | $607.0K | 1.5% | 00.0% | Unchanged | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 250 | $240.0K | 0.6% | 00.0% | Unchanged | History |
| RVPRetractable Technologies Inc | COM | 12,152 | $14.0K | <0.1% | +12,152 | New | History |
| NBISNebius Group N.V. | Stock | 17,811 | $0 | 0.0% | +17,811 | New | History |
| iShares Inc46434G780 | MSCI SINGPOR ETF | 13,600 | – | – | 00.0% | Unchanged | – |
Sold out since Q4 2023 (2)
Positions held at the end of Q4 2023 that are gone from this filing.